Clinical activity and safety of anti-programmed death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in patients (pts) with advanced melanoma (MEL) Meeting Abstract


Authors: Sosman, J.; Sznol, M.; McDermott, D. F.; Carvajal, R.; Lawrence, D. P.; Topalian, S. L.; Wigginton, J. M.; Kollia, G.; Gupta, A.; Hodi, F. S.
Abstract Title: Clinical activity and safety of anti-programmed death-1 (PD-1) (BMS-936558/MDX-1106/ONO-4538) in patients (pts) with advanced melanoma (MEL)
Meeting Title: 37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 9
Meeting Dates: 2012 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-09-01
Start Page: ix361
Language: English
ACCESSION: WOS:000309409002047
PROVIDER: wos
PUBMED: 23012731
DOI: 10.1093/annonc/mds404
Notes: Meeting Abstract: 1109O -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard D Carvajal
    148 Carvajal